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Abstract
Background: Both cell-associated and cell-free HIV virions are present in semen and cervical secretions of HIV-
infected individuals. Thus, topical microbicides may need to inactivate both cell-associated and cell-free HIV to
prevent sexual transmission of HIV/AIDS. To determine if the mild acidity of the healthy vagina and acid buffering
microbicides would prevent transmission by HIV-infected leukocytes, we measured the effect of pH on leukocyte
motility, viability and intracellular pH and tested the ability of an acidic buffering microbicide (BufferGel®) to
prevent the transmission of cell-associated HIV in a HuPBL-SCID mouse model.
Methods: Human lymphocyte, monocyte, and macrophage motilities were measured as a function of time and
pH using various acidifying agents. Lymphocyte and macrophage motilities were measured using video
microscopy. Monocyte motility was measured using video microscopy and chemotactic chambers. Peripheral
blood mononuclear cell (PBMC) viability and intracellular pH were determined as a function of time and pH using
fluorescent dyes. HuPBL-SCID mice were pretreated with BufferGel, saline, or a control gel and challenged with
HIV-1-infected human PBMCs.
Results: Progressive motility was completely abolished in all cell types between pH 5.5 and 6.0. Concomitantly,
at and below pH 5.5, the intracellular pH of PBMCs dropped precipitously to match the extracellular medium and
did not recover. After acidification with hydrochloric acid to pH 4.5 for 60 min, although completely immotile,
58% of PBMCs excluded ethidium homodimer-1 (dead-cell dye). In contrast, when acidified to this pH with
BufferGel, a microbicide designed to maintain vaginal acidity in the presence of semen, only 4% excluded dye at
10 min and none excluded dye after 30 min. BufferGel significantly reduced transmission of HIV-1 in HuPBL-SCID
mice (1 of 12 infected) compared to saline (12 of 12 infected) and a control gel (5 of 7 infected).
Conclusion: These results suggest that physiologic or microbicide-induced acid immobilization and killing of
infected white blood cells may be effective in preventing sexual transmission of cell-associated HIV.
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Background
Most HIV transmission occurs sexually [1,2], and semen
[3-6] and cervicovaginal secretions [7] contain free HIV
virions as well as HIV-infected leukocytes. Whether cell-
free virus or infected cells are the primary means of trans-
mission, or whether both are important remains
unknown.
Free virus transmits infection in monkey [8], chimpanzee
[9], and cat [10] vaginal-challenge models, although the
amount of virus used [8] has generally been greater than
the amount of infectious virus found in semen of HIV-
infected men [4]. Studies of cell-vectored transmission
include an unsuccessful attempt to establish a model of
vaginal transmission with cryopreserved SIV-infected cells
in the monkey [8], but, fresh HIV-infected cells transmit-
ted infection in the chimpanzee when applied to the cer-
vical os [9], fresh FIV-infected cells transmitted infection
after vaginal deposition in the cat [10,11], and fresh HIV-
infected human peripheral blood leukocytes transmitted
infection to SCID mice after vaginal deposition [12,13].
Notably, foreign lymphocytes are able to migrate through
vaginal mucosa and reach the iliac lymph nodes of mice
[14,15] and HIV-1 infected mononuclear cells are capable
of transmigrating through a monolayer of human epithe-
lial cells [16].
Topical microbicides are being developed to reduce the
sexual transmission of HIV and other STDs. The presence
of both free HIV virions and HIV-infected cells in sexual
secretions, and the demonstrated ability of both to trans-
mit infection in diverse animal models, suggests that
microbicide candidates should protect against cell-associ-
ated HIV as well as cell-free HIV.
Foremost, vaginal microbicides should not injure or dis-
rupt the normal vaginal flora or the vaginal epithelium;
thus, microbicides designed to enhance and maintain nat-
ural vaginal protective mechanisms merit careful consid-
eration. One natural protective mechanism is the mild
acidity found in the healthy vagina (~pH 4) that is gener-
ated predominately by the lactic acid produced by vaginal
lactobacilli [17,18] and is thought to inhibit harmful flora
and some STD pathogens. Two microbicides (Buffer-
Gel®(ReProtect, Inc., Baltimore, MD) [19-21] and Acid-
form (TOPCAD, Chicago, IL) [22]), have been developed
with the goal of strengthening and maintaining vaginal
acidity, by having sufficient buffer capacity to block the
alkalinizing action of semen. Another microbicide, CAP,
also has acidic buffering properties, which have been pos-
tulated to contribute to its activity [23-25]. BufferGel is
being tested in an HIV prevention efficacy trial (HPTN
035), and a commercially-available acidifying lubricating
gel (Replens®) is being used together with a cervical barrier
(diaphragm) in an HIV prevention trial [26].
In these studies, we examined the ability of mild acidity to
inhibit lymphocyte, monocyte and macrophage motility.
We also determined PBMC viability in mildly acidic con-
ditions, and measured the intracellular pH (pHi) to deter-
mine their ability to defend their cytoplasmic pH. We
report the effect of Carbopol®, the buffering agent con-
tained in BufferGel, on leukocyte motility and PBMC via-
bility. Finally, we tested the ability of BufferGel to reduce
transmission of cell-associated HIV in the HuPBL-SCID
mouse model.
Methods
PBMC collection
Venous blood and semen were obtained from donors
according to procedures approved by the Review Board on
the Use of Human Subjects at the Johns Hopkins Univer-
sity. PBMCs were separated on Histopaque®-1077 step
gradients (Sigma, St Louis, MO). Cells were maintained at
37°C during experiments and were used within 5 hours of
collection.
Monocyte chemotaxis
Gradient purified PBMCs were washed twice in 0.9%
saline and resuspended in 0.9% saline at a concentration
of 108 cells/ml. Monocyte chemotactic experiments were
performed using microchambers with polycarbonate fil-
ters with 5 µm pores (NeuroProbe, Cabin John, MD). The
top wells of the microchamber were filled with neutral or
acidified RPMI (Gibco, Rockville, MD) supplemented
with 1% fetal bovine serum (FBS, Gibco) and then the cell
suspension was added. RPMI was acidified with one or
combinations of the following acids: acetic acid (JT-Baker,
Phillipsburg, NJ), HCl (JT-Baker), or 2-(N-Mor-
pholino)ethanesulfonic acid (MES, Sigma). The bottom
wells were filled with RPMI supplemented with 1% FBS at
the same pH and a chemoattractant; either 0.1 µM formyl-
Met-Leu-Phe (FMLP, Sigma) or 5 µM platelet activating
factor (PAF, Sigma). The chamber assembly was then
incubated for 90 minutes at 37°C, 5% CO2. After incuba-
tion, pH in upper and lower chambers was verified to
have remained stable (± 0.1 pH units, MI-414-6 pH
microelectrode, Microelectrodes Inc., Bedford, NH), the
chambers were disassembled, stained with Diff-Quick®
(American Scientific Products, McGaw Park, IL) and the
number of monocytes that had migrated to the lower side
of the filter counted.
Monocyte, macrophage and lymphocyte chemokinesis
PBMCs separated and washed as above were resuspended
in 15 ml RPMI containing either 1% FBS for monocyte or
lymphocyte purification or 10% human serum (HS) for
macrophage maturation. Monocytes were separated from
lymphocytes by reversible fibronectin adherence [27]
resulting in ~90% monocyte purity as judged by morphol-
ogy after Diff-Quick staining. For experiments requiringBMC Infectious Diseases 2005, 5:79 http://www.biomedcentral.com/1471-2334/5/79
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macrophages, the monocytes were additionally incubated
for 3 days in RPMI containing 10% HS [28], and matured
macrophages were harvested. For lymphocyte experi-
ments, monocytes were depleted from PBMCs with
CD14-coated magnetic beads (Dynal Biotech, Lake Suc-
cess, NY) according to the manufacturer's protocol. The
remaining cells were predominantly lymphocytes (less
than 2% monocytes by Diff-Quick staining).
Leukocytes were observed by video microscopy for move-
ment on glass microscope slides (VWR, Bridgeport, NJ)
using a published method [29] modified as described
below. Monocytes and macrophages were pelleted in a
microcentrifuge at 400 G and resuspended in RPMI con-
taining 0.125% Carbopol (BF Goodrich, Cleveland, OH),
serum and chemoattractant (1% FBS and 0.1 µM FMLP for
monocytes and 10% HS and 0.1 nM FMLP for macro-
phages). Lymphocytes were resuspended in RPMI con-
taining 1% FBS, 0.1 µM FMLP, and either 50 mM MES or
0.125% Carbopol. The media had previously been
adjusted to the desired pH, and the pH of the cell suspen-
sions were verified immediately before placing them
under coverslips for video microscopy. Video recordings
were made for 15 minutes and then observed at high
speed to assess the motility of each of the 50–200 cells
contained in a low power field.
PBMC viability
PBMCs were washed in Hanks' Balanced Salt Solution
without Ca+2 and Mg+2 (HBSS; Gibco BRL), resuspended
in 10 ml RPMI, and 4 × 106 cells were placed in microcen-
trifuge tubes. Tubes were spun at 400 G for 7 minutes and
all supernatant removed using drawn out capillary tips,
and cells were resuspended in seminal plasma obtained
by centrifugation of fresh semen.
PBMCs in seminal plasma (0.05, 0.1, or 0.2 ml) were
added to glass vials containing 0.1 g of BufferGel and
stirred. Vials were maintained at 37°C during incuba-
tions. Additionally, PBMCs were resuspended in seminal
plasma with or without 0.2% Carbopol. These samples
were observed at pH 7.4 or acidified with HCl to pH 4.5.
Each cell suspension was monitored and pH adjusted
throughout the timed incubations (1–60 minutes) with
the pH microelectrode, and adjusted with 0.1 N NaOH or
HCl as necessary to maintain the pH to within 0.03 pH
units of the starting pH. After timed incubations, samples
were neutralized with 2 ml RPMI with 25 mM HEPES (pH
~8.5) (Gibco BRL) and NaOH (JT-Baker) was used as
needed to bring pH to 7.0–7.4. Neutralized cell suspen-
sions were incubated with 2 µM calcein AM and 12 µM
ethidium homodimer (Molecular Probes, Eugene, OR)
and observed with an epifluorescent Nikon E-800 micro-
scope and live and dead cells counted.
PBMC intracellular pH
PBMCs were labeled with 50 µM Oregon Green™ 488 car-
boxylic acid diacetate or 50 µM carboxyfluorescein diace-
tate (Molecular Probes) for 35 minutes. Fluorescently
labeled platelets were removed by four 120 G washes.
PBMCs were resuspended at 5 × 105 cells/ml in either
HBSS or a high potassium medium containing 17.8 mM
NaCl, 125.2 mM KCl, 8.7 mM Na2HPO4, 1 mM Ca2Cl, 1
mM MgCl2 (all JT-Baker), 1.5 mM KH2PO4, 5 mM D-glu-
cose (both Sigma). Cell viability was determined with
trypan blue (Sigma) exclusion. Standard curves were
obtained using Nigericin (Molecular Probes), a K+/H+
ionophore to equalize the intracellular and extracellular
pH of leukocytes in the high potassium medium [30-33].
Aliquots of labeled leukocytes were acidified and fluores-
cence ratio measurements were taken (ex: 490 nm/440
nm, with em: 520 nm for Carboxyfluorescein and 555 nm
for Oregon Green) as a function of time, and ratiometric
measurements were made as a function of time on an
LS50B fluorometer (Perkin Elmer, Norwalk, CT).
Intracellular pH measurements were also performed using
microscopic fluorescent ratiometry using the same dyes
and wavelengths as in the cuvette experiments. Aliquots of
PBMCs were placed onto Labtek chambered slides (Nal-
gene-Nunc International, Rochester, NY) coated with
0.1% polylysine (Sigma), labeled and washed. Individual
cells were imaged and fluorescence measured in standard
and high potassium/ionophore buffer using an Axiovert
light microscope (Zeiss, Thornwood, NY) and IP Lab soft-
ware (Scanalytics, Fairfax, VA).
HuPBL-SCID mouse model
The HuPBL-SCID mouse was used to model vaginal trans-
mission of HIV-1 as previously described [13,34]. Briefly,
SCID mice were administered uninfected human, periph-
eral blood mononuclear cells (HuPBMC) to the perito-
neal cavity one week prior to inoculation, and treated with
2.5 mg Depo-Provera (Upjohn Pharmaceutical, Kalama-
zoo, MI), which thinned the vaginal epithelium. Vaginal
inoculation of 106 HIV-1-infected HuPBMC followed vag-
inal administration of 10 µL of PBS, KY jelly, or BufferGel.
The inoculated HIV-infected cells, of which between 1 and
5% of the cells are infected with HIV-1 as demonstrated by
limiting dilution PCR, were administered on day 10 post-
infection. On day 14 following vaginal inoculation, the
mice were euthanized and cells from the peritoneal cavity,
of both human and murine origin, were collected. HIV-1-
infected cells within this population may originate from
the infected-cell inoculum, or may be the human target
cells from the peritoneal transplant within which the virus
has replicated. These cells were placed into culture with
PHA-stimulated T cells for co-culture of HIV-1, and were
detected by HIV-1 p24 antigen ELISA.BMC Infectious Diseases 2005, 5:79 http://www.biomedcentral.com/1471-2334/5/79
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Leukocyte chemotactic and chemokinetic response as a function of pH Figure 1
Leukocyte chemotactic and chemokinetic response as a function of pH. A. Monocyte chemotactic response, as 
measured by monocytes migrating through filters of nucleopore chambers, is plotted as a function of pH. Monocyte chemotac-
tic response is normalized to the maximal response for each of four repeats of the experiment (maximum response was 
between pH 7.0 and 7.3 for each repeat). The cells were in RPMI containing 50 mM MES. Similar results were observed when 
the media were acidified with buffering systems consisting of 20 mM acetic acid, 20 mM MES and 20 mM acetic acid, and 1 N 
HCl and when PAF was used as an alternative chemoattractant (data not shown). B. Monocyte (circles) and macrophage 
(squares) chemokinesis, as measured by observing cells migrating on glass slides, is plotted as a function of pH. The percent 
response was determined by the number of motile cells divided by the total number of cells (50–200) observed at each pH. 
The cells were in RPMI containing 0.125% Carbopol. C. Lymphocyte (triangles) chemokinesis is plotted as a function of pH. 
The percent response was determined as in B. The cells were in RPMI containing 50 mM MES (open triangles) or RPMI con-
taining 0.125% Carbopol (closed triangles). Nonlinear regression was used to fit a sigmoidal curves for each data set: A: R = 
0.95; B: R = 0.95, monocytes, 0.99 macrophages; C: R = .98 lymphocytes with Carbopol, R = .96 with MES. The minimum 
value was set to 0 for all curves and the maximum value to 100 for monocyte and macrophage curves. The bracket from pH 
3.7 to 4.4 on the x axis of panel C indicates the pH range in a healthy, lactobacilli dominated vagina.BMC Infectious Diseases 2005, 5:79 http://www.biomedcentral.com/1471-2334/5/79
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Statistics
Results from leukocyte chemotaxis and chemokinesis
experiments were fit with sigmoidal curves by nonlinear
regression. Curves were fit to the four parameter logistics
equation [35]:
y = ((d-a)/(1+(x/c)b)) + a
where a is the maximum asymptote, b is the slope of the
linear region of the curve, c is the midpoint of the linear
region, and d is the minimum asymptote. For monocytes
and macrophages, the maximum asymptote was set to
100 and for all three cell types, the minimum asymptote
was set to 0, since values above 100 and below 0 are not
physiological.
Statistical analyses were performed using SPSS® statistical
software version 10.0 (SPSS Inc., Chicago, IL). Results
from the PBMC viability experiments were analyzed by
analysis of variance for the main effects of time and pH
and for their interaction. Post hoc pair-wise group com-
parisons were made using Schéffe's multiple comparison
procedure. A linear regression model was developed to
determine whether there was a significant difference in
viability between PBMCs acidified with HCl and Buffer-
Gel, after adjusting for the effects of time and the interac-
tion between time and the acidifying agent. Results for the
Hu-PBL SCID mouse model were analyzed with a two
sided Fisher's exact test.
Results
Monocyte chemotactic response was observed using
chemotactic chambers, over the pH range of pH 5.0 to 7.5,
in RPMI acidified and buffered with 50 mM MES. Mono-
cytes attracted by FMLP crawl through a filter separating
two chambers filled with media. The percent response
normalized to maximal response (pH 7.0–7.5) is plotted
for four experiments (Fig. 1A). Chemotaxis was essentially
blocked below pH 5.8. Similar results were observed
when the media were acidified with buffering systems
consisting of 20 mM acetic acid, 20 mM MES and 20 mM
acetic acid, and 1 N HCl without additional buffering
agent and when PAF was used as the chemoattractant
(data not shown).
Since Carbopol consists of micron-sized clusters of lightly
cross-linked polymer, it clogged the filters of the micro-
chamber assembly. Therefore, monocyte, macrophage,
and lymphocyte chemokinesis were observed in RPMI
containing FMLP and 0.125% Carbopol or 50 mM MES
by videotaping cells migrating on glass slides. In all cases,
nearly all motility ceased below pH 5.8 (Fig. 1B and 1C).
The chemokinesis results for monocytes, macrophages,
and lymphocytes were similar to the results for monocyte
chemotaxis through filters. Although monocytes and
macrophages were occasionally able to change shape
between pH 5 and 6, progressive motility was never
observed below pH 6.0. Lymphocytes exhibited lower
maximal motility rates at neutral pH (40–50%) than
monocytes or macrophages (85–100%).
To determine if the loss of cell motility was due to killing
of the PBMCs, cell viability was tested using a fluorescent
live/dead cell assay [36]. As shown in Fig. 2, PBMCs in
seminal plasma acidified with HCl to pH 4.5 maintained
their viability substantially longer than PBMCs in seminal
plasma acidified with BufferGel to pH 4.5 (P = 0.001).
When acidified with HCl, 80% of PBMCs were still viable
at 30 minutes, but when acidified to this same pH with
BufferGel, less than 10% were viable at 5 minutes and
none were viable at 30 minutes. To test if this enhanced
killing was due to Carbopol, or other constituents or the
gel structure of BufferGel, PBMCs were resuspended in
seminal plasma containing 0.2% Carbopol (approxi-
mately 20-fold lower concentration than in BufferGel)
and adjusted to pH 4.5 with HCl, and the viability was
measured. This is also relevant for situations where the
concentration of Carbopol may be low due to uneven dis-
tribution of gel in the vagina. At 30 minutes, 50% of
PBMCs in pH 4.5 RPMI containing 0.2% Carbopol were
viable. However, PBMCs incubated with 0.2% Carbopol
at pH 7.4 had no reduction in viability over one hour.
PBMC pHi was measured as a function of extracellular pH
(pHe) to investigate potential mechanisms mediating the
acid immobilization and killing of PBMCs. At every pH
tested, pHi equilibrated with pHe within 2 minutes (Fig.
3). At pHe as low as 6.0, however, PBMCs were able to
restore their pHi to approximately 7.5 within 10 minutes.
However, at pH 5.5 and below, PBMCs were unable to
restore their normal pHi, even after 60 minutes.
Control experiments using fluorescent microscopy were
performed measuring the fluorescence ratio of individual
cells and of the surrounding buffer, to detect artifacts due
to possible dye leakage out of cells and inadvertent obser-
vation of dye in the extracellular buffer. These results
showed that dye leakage was not a factor and that, as with
the cuvette method, pHi dropped to pHe at both pHe 5.5
and 5.0 and pHi did not recover (data not shown).
Three groups of mice were challenged with cell-associated
HIV in the HuPBL-SCID mouse model. Depo-Provera
treated mice were treated with BufferGel, PBS (control), or
KY Jelly (gel control) prior to infected-cell challenge. One
of 12 mice pretreated with BufferGel became infected with
HIV, 12 of 12 mice pretreated with PBS became infected,
and 5 of 7 mice pretreated with KY Jelly became infected.
BufferGel provided significant protection compared to KY
jelly (P < 0.01) and saline (P < 0.0001).BMC Infectious Diseases 2005, 5:79 http://www.biomedcentral.com/1471-2334/5/79
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Discussion
During reproductive years, the pH of a healthy human
vagina is usually pH 4–4.5 [37]. However, Masters and
Johnson showed that an ejaculate acts as a potent alkaline
buffer, which abolishes vaginal acidity within seconds
and keeps the vagina neutralized (pH 6–7) for several
hours after intercourse [38]. During this time acid-sensi-
tive sperm and microbes can reach their targets or enter
the upper reproductive tract. Maintaining the normal
acidic condition of the vagina during and after intercourse
is thus a potential method for preventing conception as
well as STDs.
Here we describe the effect of low pH on the motility and
viability of leukocytes that may serve as vectors for sexual
transmission of HIV and present data indicating that Buff-
erGel reduces vaginal transmission of cell-associated HIV
in the HuPBL-SCID mouse model. We found that mono-
cytes, macrophages and lymphocytes all completely lose
progressive motility at a pH slightly below 6.0 (Fig. 1).
The results were similar in the presence of a variety of buff-
ering species, including Carbopol, and with a second che-
moattractant, platelet activating factor. Our results are
consistent with those of Fischer, et al, who showed that
lymphocytes lose cytotoxic activity and other immuno-
logical functions when the extracellular pH falls to 5.8
[39,40] and with Hill and Anderson who showed that
lymphocyte proliferation is abolished at pH < 6 [41].
Acidity dramatically reduced leukocyte viability in this
study. When acidified with BufferGel, PBMCs added to
seminal plasma were rapidly killed at pH 4.0 and 4.5, and
killed more slowly at pH 5.0 (Fig. 2). Both BufferGel and
Viability of PBMCs as a function of time and pH Figure 2
Viability of PBMCs as a function of time and pH. 
PBMCs in seminal plasma were mixed in various volume 
ratios (1:2, 1:1, 2:1) with BufferGel to give final pH values of 
4.0, 4.5 and 5.0. Live PBMCs (as detected calcein-AM) and 
dead PBMCs (as detected by ethidium homodimer) were 
counted as a function of time and pH. As a comparison, 
PBMCs in seminal plasma were mixed with a 0.2% Carbopol 
(approximately 1/20th the amount in BufferGel), and acidified 
to pH 4.5 with HCl, or maintained at pH 7.4. Also, PBMCs in 
seminal plasma without Carbopol were acidified to pH 4.5 
with HCl. Each point represents the mean (± SD) of three to 
six experiments. For experiments with BufferGel, results of 
analysis of variance for the main effects of pH and time and 
their interaction were P < 0.001. Scheffe's multiple compari-
son procedure was used to compare pH effects. The pH 5.0 
curve is significantly different from the pH 4.0 and 4.5 curves 
(P < 0.001). By linear regression, the pH 4.5 BufferGel curve 
is significantly different from the pH 4.5 HCl curve (P < 
0.001).
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The effect of extracellular pH on intracellular pH of 
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utes. At pHe 5.5 and below, PBMCs are unable to recover 
their intracellular pH. Points are mean (± SD) of three 
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Carbopol alone enhanced acid-killing of PBMCs com-
pared to acidification with HCl alone.
In the SCID mouse model of vaginal HIV transmission,
pretreatment of mice with BufferGel, as compared with
saline, significantly reduced the transmission of cell-asso-
ciated HIV. In addition, BufferGel provided significant
protection compared to another gel, KY Jelly. We and oth-
ers have shown similar protection using this model with
other microbicide candidates [13,42-44].
Importantly, despite the cell killing potential of acidity
especially in the presence of BufferGel, BufferGel has
proven to be non-toxic to cervicovaginal epithelium in
vivo in two high-dose tolerance Phase I trials [19,45] and
in a highly sensitive acute vaginal toxicity mouse model
[46]. We hypothesize that this advantageous differential
toxicity (toxic to potentially infectious human leukocytes,
but non-toxic to human epithelia in vivo) may be due to a
greater ability of the epithelium to maintain the pHi of its
surface cells because these cells can export protons to
underlying vascularized tissue. In contrast, individual
cells or pathogens surrounded by an acidic environment
within the vaginal lumen must pump out protons against
a high gradient over their entire surface area. Thus,
although demonstrably cytotoxic to human white blood
cells in vitro, and able to prevent cell-associated HIV trans-
mission in the vagina lumen in an animal model, acidic
buffering appears to have minimal or no cytotoxicity to
the human genital tract epithelium.
Our results demonstrate that mild acidity inactivates the
motility and viability of leukocytes that may act as vectors
for sexual transmission of HIV [47,48] and reduces trans-
mission of HIV in a mouse model. These results are
consistent with other studies that have shown that the nat-
ural vaginal acidity may help reduce HIV transmission in
women. Women with abundant vaginal lactobacilli have
a lower HIV susceptibility compared to women with bac-
terial vaginosis [49,50], a condition in which vaginal
lactobacilli, and therefore, vaginal acidity, are lost. It has
been suggested that reduction of cervicovaginal viral load
by physiological vaginal acidity may reduce both male to
female, and female to male transmission of HIV [51,52].
In a study of HIV infected women, vaginal lavages with a
pH < 4.5 showed a trend to contain less cultivatable HIV
virus than lavages with a pH ≥ 4.5 (P = 0.08) when tested
with the multinuclear-activation galactosidase indicator
(MAGI) assay [52] possibly indicating a reduction in HIV
load and a reduction in risk of transmission at lower pH
values. Moreover, another study showed that exposure to
acidic cervico-vaginal secretions reduce HIV viability as
detected by cocultivation with PBMCs [51].
To gain understanding about how acid pH mediates the
immobilization and killing of leukocytes we measured
the pHi of PBMCs in acidified medium. Intracellular fluo-
rescent pH probes have been used to measure the pHi of
human leukocytes in a number of studies [39,53-57].
Most previous studies have concentrated on leukocyte
activation and small changes in pHi (pH ~0.5) and
minor reductions in pHe. One study, exploring leukocyte
function near tumors (known to have a low pHe), showed
that PBMCs incubated for four hours at low pHe were una-
ble to maintain their pHi below pHe 6.5 [39]. In our exper-
iments with PBMCs, a significant and continued
perturbation of pHi was observed at and below a pHe of
5.5, indicating that PBMCs are unable to defend their pHi
below this pHe (Fig. 3). At pHe of 6.0 and above, PBMCs
restored their normal pHi within 10 minutes. However,
even after 60 minutes, PBMCs were unable to restore their
normal pHi after exposure to a pHe of 5.5. Considering
that pHi exerts profound influence on the apoptosis path-
way [58], intracellular enzyme functions, protein stability,
and other molecular interactions, we believe the observed
prolonged perturbation of pHi is the likely cause of the
observed loss of motility and viability at low pHe.
Conclusion
We found that human leukocytes lose motility and viabil-
ity at pH levels typically found in a healthy vagina and
that BufferGel reduces transmission of HIV in HuPBL-
SCID mice. These results support the hypothesis that
physiologic vaginal flora and vaginal acidity may reduce
female to male HIV transmission via HIV-infected cell vec-
tors. Our results further suggest that by helping to
maintain acidity that would otherwise be abolished by
semen [38,51], BufferGel, a broad spectrum microbicide/
spermicide [20,21], may enhance the natural protection
of vaginal acidity by killing or immobilizing infected cell
vectors in semen, and may thus reduce male to female
transmission.
Competing interests
Cone and Moench are developers of BufferGel and
Khanna is an employee of ReProtect Inc. All three hold
equity in ReProtect, Inc.
Authors' contributions
SO participated in the design of the study, conducted pHi
experiments, assisted with statistical analysis, assisted in
data analysis and drafted the manuscript. RC conceived of
the study, assisted in data analysis, and helped draft the
manuscript. KK designed and conducted the HuPBL-SCID
mouse experiments, assisted in data analysis, and helped
draft the manuscript. EN conducted viability and chemo-
kinesis experiments, and assisted in data analysis. SW
participated in the design of the study, conducted chemo-
taxis and chemokinesis experiments, and participated inBMC Infectious Diseases 2005, 5:79 http://www.biomedcentral.com/1471-2334/5/79
Page 8 of 9
(page number not for citation purposes)
analysis of the data. OJ conducted pHi experiments and
assisted in data analysis. RM helped design the HuPBL-
SCID mouse experiments and assisted in data analysis.
TM conceived of and designed the study, supervised
experiments, assisted in data analysis, and helped draft
the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
The authors thank Leslie A. Meyn, M.S., Magee-Womens Research Insti-
tute, Pittsburgh, PA, for statistical analysis and Usman Bacha, Johns Hopkins 
University, for fluorescent microscopy on individual cells. This work was 
supported by National Institute of Health Training Grant GM07231-23 
(SSO, STW), National Institutes of Health Program Project Grant P01-
AI45967, Gustave Martin Innovative Research Award from the Department 
of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg 
School of Public Health (KK) and ReProtect, Inc.
References
1. Auerbach DM, Darrow WW, Jaffe HW, Curran JW: Cluster of
cases of the acquired immune deficiency syndrome. Patients
linked by sexual contact.  Am J Med 1984, 76:487-492.
2. Chamberland ME, Castro KG, Haverkos HW, Miller BI, Thomas PA,
Reiss R, Walker J, Spira TJ, Jaffe HW, Curran JW: Acquired immu-
nodeficiency syndrome in the United States: an analysis of
cases outside high-incidence groups.  Ann Intern Med 1984,
101:617-623.
3. Pilcher CD, Tien HC, Eron JJJ, Vernazza PL, Leu SY, Stewart PW, Goh
LE, Cohen MS: Brief but efficient: acute HIV infection and the
sexual transmission of HIV.  J Infect Dis 2004, 189:1785-1792.
4. Vernazza PL, Gilliam BL, Dyer J, Fiscus SA, Eron JJ, Frank AC, Cohen
MS: Quantification of HIV in semen: correlation with antiviral
treatment and immune status.  AIDS 1997, 11:987-993.
5. Quayle AJ, Xu C, Mayer KH, Anderson DJ: T lymphocytes and
macrophages, but not motile spermatozoa, are a significant
source of human immunodeficiency virus in semen.  J Infect Dis
1997, 176:960-968.
6. Tachet A, Dulioust E, Salmon D, De Almeida M, Rivalland S, Finkielsz-
tejn L, Heard I, Jouannet P, Sicard D, Rouzioux C: Detection and
quantification of HIV-1 in semen: identification of a subpop-
ulation of men at high potential risk of viral sexual
transmission.  AIDS 1999, 13:823-831.
7. Hart CE, Lennox JL, Pratt-Palmore M, Wright TC, Schinazi RF, Evans-
Strickfaden T, Bush TJ, Schnell C, Conley LJ, Clancy KA, Ellerbrock
TV: Correlation of human immunodeficiency virus type 1
RNA levels in blood and the female genital tract.  J Infect Dis
1999, 179:871-882.
8. Sodora DL, Gettie A, Miller CJ, Marx PA: Vaginal transmission of
SIV: assessing infectivity and hormonal influences in
macaques inoculated with cell-free and cell-associated viral
stocks.  AIDS Res Hum Retroviruses 1998, 14 Suppl 1:S119-23.
9. Girard M, Mahoney J, Wei Q, van der Ryst E, Muchmore E, Barre-
Sinoussi F, Fultz PN: Genital infection of female chimpanzees
with human immunodeficiency virus type 1.  AIDS Res Hum
Retroviruses 1998, 14:1357-1367.
10. Burkhard MJ, Obert LA, O'Neil LL, Diehl LJ, Hoover EA: Mucosal
transmission of cell-associated and cell-free feline immuno-
deficiency virus.  AIDS Res Hum Retroviruses 1997, 13:347-355.
11. Moench TR, Whaley KJ, Mandrell TD, Bishop BD, Witt CJ, Cone RA:
The cat/feline immunodeficiency virus model for transmu-
cosal transmission of AIDS: nonoxynol-9 contraceptive jelly
blocks transmission by an infected cell inoculum.  AIDS 1993,
7:797-802.
12. Di Fabio S, Giannini G, Lapenta C, Spada M, Binelli A, Germinario E,
Sestili P, Belardelli F, Proietti E, Vella S: Vaginal transmission of
HIV-1 in hu-SCID mice: a new model for the evaluation of
vaginal microbicides.  AIDS 2001, 15:2231-2238.
13. Khanna KV, Whaley KJ, Zeitlin L, Moench TR, Mehrazar K, Cone RA,
Liao Z, Hildreth JE, Hoen TE, Shultz L, Markham RB: Vaginal trans-
mission of cell-associated HIV-1 in the mouse is blocked by a
topical, membrane-modifying agent.  J Clin Invest 2002,
109:205-211.
14. Ibata B, Parr EL, King NJ, Parr MB: Migration of foreign lym-
phocytes from the mouse vagina into the cervicovaginal
mucosa and to the iliac lymph nodes.  Biol Reprod 1997,
56:537-543.
15. Zacharopoulos VR, Perotti ME, Phillips DM: A role for cell migra-
tion in the sexual transmission of HIV-1?  Curr Biol 1997,
7:534-537.
16. Carreno MP, Chomont N, Kazatchkine MD, Irinopoulou T, Krief C,
Mohamed AS, Andreoletti L, Matta M, Belec L: Binding of LFA-1
(CD11a) to intercellular adhesion molecule 3 (ICAM-3;
CD50) and ICAM-2 (CD102) triggers transmigration of
human immunodeficiency virus type 1-infected monocytes
through mucosal epithelial cells.  J Virol 2002, 76:32-40.
17. Boskey ER, Cone RA, Whaley KJ, Moench TR: Origins of vaginal
acidity: high D/L lactate ratio is consistent with bacteria
being the primary source.  Hum Reprod 2001, 16:1809-1813.
18. Boskey ER, Telsch KM, Whaley KJ, Moench TR, Cone RA: Acid pro-
duction by vaginal flora in vitro is consistent with the rate
and extent of vaginal acidification.  Infect Immun 1999,
67:5170-5175.
19. Mayer K, Peipert J, Fleming T, Fullem A, Moench T, Cu-Uvin S, Bent-
ley M, Chesney M, Rosenberg Z: Safety and tolerability of buffer-
gel, a novel vaginal microbicide, in women in the united
states.  Clin Infect Dis 2001, 32:476-482.
20. Olmsted SS, Dubin NH, Cone RA, Moench TR: The rate at which
human sperm are immobilized and killed by mild acidity.  Fer-
til Steril 2000, 73:687-693.
21. Zeitlin L, Hoen TE, Achilles SL, Hegarty TA, Jerse AE, Kreider JW,
Olmsted SS, Whaley KJ, Cone RA, Moench TR: Tests of Buffergel
for contraception and prevention of sexually transmitted
diseases in animal models.  Sex Transm Dis 2001, 28:417-423.
22. Amaral E, Faundes A, Zaneveld L, Waller D, Garg S: Study of the
vaginal tolerance to Acidform, an acid-buffering, bioadhesive
gel.  Contraception 1999, 60:361-366.
23. Neurath AR, Li YY, Mandeville R, Richard L: In vitro activity of a
cellulose acetate phthalate topical cream against organisms
associated with bacterial vaginosis.  J Antimicrob Chemother 2000,
45:713-714.
24. Neurath AR, Strick N, Li YY: Water dispersible microbicidal cel-
lulose acetate phthalate film.  BMC Infect Dis 2003, 3:27.
25. Neurath AR, Strick N, Li YY, Lin K, Jiang S: Design of a "microbi-
cide" for prevention of sexually transmitted diseases using
"inactive" pharmaceutical excipients.  Biologicals 1999,
27:11-21.
26. Meehan A, Chidanyika A, Naidoo S, Didier L, Ramjee G, Chipato T,
Dinat N, Blanchard K, team MIRA, Padian N: Prevalence and Risk
Factors for HIV Infection in Zimbabwean and South African
Women: Preliminary analysis of the MIRA trial screening
population.: ; The XV International AIDS Conference; Bang-
kok, Thailand.  ; 2004. 
27. Jones BM, Nicholson JK, Holman RC, Hubbard M: Comparison of
monocyte separation methods using flow cytometric
analysis.  J Immunol Methods 1989, 125:41-47.
28. Dougherty GJ, McBride WH: Monocyte Differentiation in vitro.
In Human Monocytes Edited by: Zembala M and Asherson GL. San
Diego, Academic Press; 1989:49-58. 
29. Huu TP: Chemotaxis of leucocytes: an improved method of
direct microscopic observation.  Ann Immunol (Paris) 1977,
128C:763-770.
30. Bright GR, Fisher GW, Rogowska J, Taylor DL: Fluorescence ratio
imaging microscopy: temporal and spatial measurements of
cytoplasmic pH.  J Cell Biol 1987, 104(4):1019-1033.
31. Chaillet JR, Boron WF: Intracellular calibration of a pH-sensi-
tive dye in isolated, perfused salamander proximal tubules.  J
Gen Physiol 1985, 86:765-794.
32. Tanasugarn L, McNeil P, Reynolds GT, Taylor DL: Microspec-
trofluorometry by digital image processing: measurement of
cytoplasmic pH.  J Cell Biol 1984, 98(2):717-724.
33. Thomas JA, Buchsbaum RN, Zimniak A, Racker E: Intracellular pH
measurements in Ehrlich ascites tumor cells utilizing spec-
troscopic probes generated in situ.  Biochemistry 1979,
18:2210-2218.
34. Khanna KV, Whaley KJ, Zeitlin L, Ford DH, Markham RB: Vaginal
transmission of HIV-1 in Hu-PBL-SCID mice.: ; Poster 11215Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Infectious Diseases 2005, 5:79 http://www.biomedcentral.com/1471-2334/5/79
Page 9 of 9
(page number not for citation purposes)
at Twelth World AIDS Conference; Geneva, Switzerland.  ;
1998. 
35. Rodbard D, Hutt DM: Statistical analysis of radioimmunoassays
and immunoradiometric (labeled antibody) assays: ;
Istanbul.  Volume 1. International Atomic Energy Agency;
1973:165-192. 
36. Burghardt RC, Barhoumi R, Doolittle DJ, Philips TD: Application of
Cellular Fluorescence Imaging for In Vitro Toxicology Test-
ing.  In Principles and Methods of Toxicology 3rd edition. Edited by:
Hayes AW. New York, Raven Press; 1994:1231-1258. 
37. Larsen B: Vaginal flora in health and disease.  Clin Obstet Gynecol
1993, 36:107-121.
38. Masters WH, Johnson VE: The physiology of the vaginal repro-
ductive function.  Western J Surg 1961, 69:105-120.
39. Fischer B, Muller B, Fischer KG, Baur N, Kreutz W: Acidic pH
inhibits non-MHC-restricted killer cell functions.  Clin Immunol
2000, 96:252-263.
40. Fischer B, Muller B, Fisch P, Kreutz W: An acidic microenviron-
ment inhibits antitumoral non-major histocompatibility
complex-restricted cytotoxicity: implications for cancer
immunotherapy.  J Immunother 2000, 23:196-207.
41. Hill JA, Anderson DJ: Human vaginal leukocytes and the effects
of vaginal fluid on lymphocyte and macrophage defense
functions.  Am J Obstet Gynecol 1992, 166:720-726.
42. Di Fabio S, Giannini G, Spada M, Binelli A, Germinario E, Lapenta C,
Carlini F, Belardelli F, Vella S: Efficacy of PRO 2000/5 Gel in a hu-
SCID Mouse Model for Vaginal Transmission of Cell-associ-
ated HIV: ; Microbicides 2004; London.  ; 2004. 
43. Di Fabio S, Van Roey J, Giannini G, van den Mooter G, Spada M, Binelli
A, Pirillo MF, Germinario E, Belardelli F, de Bethune MP, Vella S: Inhi-
bition of vaginal transmission of HIV-1 in hu-SCID mice by
the non-nucleoside reverse transcriptase inhibitor TMC120
in a gel formulation.  Aids 2003, 17:1597-1604.
44. D'Cruz OJ, Samuel P, Uckun FM: PHI-443: a novel noncontracep-
tive broad-spectrum anti-human immunodeficiency virus
microbicide.  Biol Reprod 2004, 71:2037-2047.
45. van De Wijgert J, Fullem A, Kelly C, Mehendale S, Rugpao S, Kum-
wenda N, Chirenje Z, Joshi S, Taha T, Padian N, Bollinger R, Nelson
K: Phase 1 trial of the topical microbicide BufferGel: safety
results from four international sites.  J Acquir Immune Defic Syndr
2001, 26:21-27.
46. Achilles SL, Shete PB, Whaley KJ, Moench TR, Cone RA: Microbi-
cide Efficacy and Toxicity Tests in a Mouse Model for Vaginal
Transmission of Chlamydia trachomatis.  Sex Transm Dis 2002,
29:655-664.
47. Levy JA: The transmission of AIDS: the case of the infected
cell.  Jama 1988, 259:3037-3038.
48. Anderson DJ, Yunis EJ: "Trojan Horse" leukocytes in AIDS.  N
Engl J Med 1983, 309:984-985.
49. Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA,
Yang LP, Liomba GN, Broadhead RL, Chiphangwi JD, Miotti PG: Bac-
terial vaginosis and disturbances of vaginal flora: association
with increased acquisition of HIV.  AIDS 1998, 12:1699-1706.
50. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan
B, Mandaliya K, Ndinya-Achola JO, Bwayo J, Kreiss J: Vaginal lacto-
bacilli, microbial flora, and risk of human immunodeficiency
virus type 1 and sexually transmitted disease acquisition.  J
Infect Dis 1999, 180:1863-1868.
51. Tevi-Benissan C, Belec L, Levy M, Schneider-Fauveau V, Si Mohamed
A, Hallouin MC, Matta M, Gresenguet G: In vivo semen-associated
pH neutralization of cervicovaginal secretions.  Clin Diagn Lab
Immunol 1997, 4:367-374.
52. Cummins JEJ, Villanueva JM, Evans-Strickfaden T, Sesay SM, Abner SR,
Bush TJ, Green TA, Lennox JL, Wright T, Folks TM, Hart CE, Dezzutti
CS: Detection of infectious human immunodeficiency virus
type 1 in female genital secretions by a short-term culture
method.  J Clin Microbiol 2003, 41:4081-4088.
53. Grinstein S, Cohen S, Lederman HM, Gelfand EW: The intracellu-
lar pH of quiescent and proliferating human and rat thymic
lymphocytes.  J Cell Physiol 1984, 121:87-95.
54. Grinstein S, Cohen S, Rothstein A: Cytoplasmic pH regulation in
thymic lymphocytes by an amiloride-sensitive Na+/H+
antiport.  J Gen Physiol 1984, 83:341-369.
55. Swallow CJ, Grinstein S, Rotstein OD: Cytoplasmic pH regulation
in macrophages by an ATP-dependent and N,N'-dicyclohex-
ylcarbodiimide-sensitive mechanism. Possible involvement
of a plasma membrane proton pump.  J Biol Chem 1988,
263:19558-19563.
56. Swallow CJ, Grinstein S, Rotstein OD: Regulation of cytoplasmic
pH in resident and activated peritoneal macrophages.  Bio-
chim Biophys Acta 1990, 1022:203-210.
57. Swallow CJ, Grinstein S, Rotstein OD: Regulation and Functional
Significance of Cytoplasmic pH in Phagocytic Leukocytes.  In
Mechanisms of leukocyte activation Edited by: Grinstein S and Rotstein
OD. San Diego, Academic Press; 1990:227-247. 
58. Meisenholder GW, Martin SJ, Green DR, Nordberg J, Babior BM,
Gottlieb RA: Events in apoptosis. Acidification is downstream
of protease activation and BCL-2 protection.  J Biol Chem 1996,
271:16260-16262.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2334/5/79/prepub